标题
Influenza vaccines: Evaluation of the safety profile
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 14, Issue 3, Pages 657-670
出版商
Informa UK Limited
发表日期
2018-01-03
DOI
10.1080/21645515.2017.1423153
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis
- (2018) Tomi O. Sarkanen et al. SLEEP MEDICINE REVIEWS
- Immune responses after live attenuated influenza vaccination
- (2018) Kristin G.-I. Mohn et al. Human Vaccines & Immunotherapeutics
- Strategies in recommending influenza vaccination in Europe and US
- (2018) Caterina Rizzo et al. Human Vaccines & Immunotherapeutics
- Beliefs and attitudes towards the influenza vaccine in high-risk individuals
- (2017) A. J. SANTOS et al. EPIDEMIOLOGY AND INFECTION
- Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16
- (2017) Hélène Bricout et al. Eurosurveillance
- Excess mortality in Italy: Should we care about low influenza vaccine uptake?
- (2017) Francia Fausto et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years
- (2017) Roger Baxter et al. VACCINE
- Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial
- (2017) Anuradha Madan et al. VACCINE
- Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis
- (2017) Krista Wilkinson et al. VACCINE
- Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines
- (2017) Kathleen M. Neuzil et al. VACCINE
- Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study
- (2017) John T. Treanor et al. VACCINE
- Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trials
- (2017) W.E.P. Beyer et al. VACCINE
- Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
- (2017) Zhaojun Mo et al. Human Vaccines & Immunotherapeutics
- Comparison of side effects of the 2015-2016 high dose, inactivated, trivalent influenza vaccine and standard dose, inactivated, trivalent influenza vaccine in adults >=65 years.
- (2017) Anjum S. Kaka et al. Open Forum Infectious Diseases
- Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
- (2016) Natasha B. Halasa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database
- (2016) Enrique Alcalde-Cabero et al. BMC Neurology
- Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
- (2016) Rhian McNaughton et al. DRUG SAFETY
- Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention
- (2016) Pedro L. Moro et al. Expert Opinion On Drug Safety
- Influenza immunology evaluation and correlates of protection: a focus on vaccines
- (2016) Claudia Maria Trombetta et al. Expert Review of Vaccines
- Evaluating influenza vaccines: progress and perspectives
- (2016) Elena Gianchecchi et al. Future Virology
- Anaphylaxis After Immunization of Children and Adolescents in Germany
- (2016) Doris Oberle et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons
- (2016) Rongxia Li et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children
- (2016) Susanna Esposito et al. VACCINE
- Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials
- (2016) Aye M. Moa et al. VACCINE
- Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study
- (2016) Terry Nolan et al. VACCINE
- Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection
- (2016) Hana Hakim et al. VACCINE
- Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013−May 31, 2015
- (2016) Penina Haber et al. VACCINE
- Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2–17 years of age in 2013–2014 in the United States
- (2016) Herve Caspard et al. VACCINE
- Vaccinology in the third millennium: scientific and social challenges
- (2016) Gregory A Poland et al. Current Opinion in Virology
- Safety, immunogenicity and cross-reactivity of a Northern hemisphere 2013–2014 seasonal trivalent inactivated split influenza virus vaccine, Anflu®
- (2016) Yonggang Shen et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study
- (2016) Stephan Bart et al. Human Vaccines & Immunotherapeutics
- Prevention and Control of Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season
- (2015) AMERICAN JOURNAL OF TRANSPLANTATION
- Gene/environment interactions in the pathogenesis of autoimmunity: New insights on the role of Toll-like receptors
- (2015) Elena Gianchecchi et al. AUTOIMMUNITY REVIEWS
- Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials
- (2015) Claudia Pileggi et al. BMC INFECTIOUS DISEASES
- Long-Term Immunogenicity and Safety of a Conventional Influenza Vaccine in Patients with Type 2 Diabetes
- (2015) Yu Bin Seo et al. Clinical and Vaccine Immunology
- Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study
- (2015) Sara Ghaderi et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Current and next generation influenza vaccines: Formulation and production strategies
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children
- (2015) J Li-Kim-Moy et al. Eurosurveillance
- Flucelvax (Optaflu) for seasonal influenza
- (2015) Ilaria Manini et al. Expert Review of Vaccines
- Safety, immunogenicity and infectivity of new live attenuated influenza vaccines
- (2015) Irina Isakova-Sivak et al. Expert Review of Vaccines
- A review of the changes to the licensing of influenza vaccines in Europe
- (2015) Leonoor Wijnans et al. Influenza and Other Respiratory Viruses
- Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination
- (2015) Javier Díez-Domingo et al. Influenza and Other Respiratory Viruses
- Safety of a Pandemic Influenza Vaccine and the Immune Response in Patients with Duchenne Muscular Dystrophy
- (2015) Tomoko Saito et al. INTERNAL MEDICINE
- Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
- (2015) Mahdee Sobhanie et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan
- (2015) Yukari Tsurudome et al. MICROBIOLOGY AND IMMUNOLOGY
- Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2
- (2015) Syed Sohail Ahmed et al. Science Translational Medicine
- Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
- (2015) Markus Knuf et al. VACCINE
- The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper
- (2015) Neal A. Halsey et al. VACCINE
- Serologic response after vaccination against influenza (A/H1N1)pdm09 in children with renal disease receiving oral immunosuppressive drugs
- (2015) Seiji Tanaka et al. VACCINE
- Post-marketing surveillance of adverse events following immunization with inactivated quadrivalent and trivalent influenza vaccine in health care providers in Western Australia
- (2015) Annette K. Regan et al. VACCINE
- Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age
- (2015) Ruvim Izikson et al. VACCINE
- Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age
- (2015) Carlos A. DiazGranados et al. VACCINE
- Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial
- (2015) Joon Young Song et al. VACCINE
- Guillain-Barré syndrome and influenza vaccines: A meta-analysis
- (2015) L.H. Martín Arias et al. VACCINE
- Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: A randomized phase 1/2 clinical trial
- (2015) Ryo Arakane et al. VACCINE
- Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
- (2015) Paul J Turner et al. BMJ-British Medical Journal
- A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine - Assessing the immunogenicity and safety in an open label, uncontrolled study
- (2015) Louise Roggelin et al. Human Vaccines & Immunotherapeutics
- Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine
- (2015) Yu Bin Seo et al. Human Vaccines & Immunotherapeutics
- Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
- (2015) José Garcia-Sicilia et al. Human Vaccines & Immunotherapeutics
- Influenza vaccination in children primed with MF59®-adjuvanted or non-adjuvanted seasonal influenza vaccine
- (2015) Timo Vesikari et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children
- (2015) Markus Knuf et al. Human Vaccines & Immunotherapeutics
- Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study
- (2015) Paul J Turner et al. BMJ-British Medical Journal
- Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized Trial
- (2015) Long Wang et al. Journal of the Pediatric Infectious Diseases Society
- A Comparison of Active Adverse Event Surveillance Systems Worldwide
- (2014) Yu-Lin Huang et al. DRUG SAFETY
- Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial
- (2014) Terry Nolan et al. JOURNAL OF INFECTIOUS DISEASES
- Association Between Antibody Titers and Protection Against Influenza Virus Infection Within Households
- (2014) Tim K. Tsang et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age
- (2014) Miguel A. Rodriguez Weber et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children
- (2014) Terry Nolan et al. VACCINE
- Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial
- (2014) Juan Carlos Tinoco et al. VACCINE
- Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
- (2014) Sharon E. Frey et al. VACCINE
- A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months
- (2014) Alfonso Carmona Martinez et al. Human Vaccines & Immunotherapeutics
- A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination
- (2014) Keith S Reisinger et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial
- (2014) Joanne M. Langley et al. Journal of the Pediatric Infectious Diseases Society
- Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age
- (2014) Natasha B. Halasa et al. Journal of the Pediatric Infectious Diseases Society
- Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
- (2013) Dorothee Kieninger et al. BMC INFECTIOUS DISEASES
- Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France
- (2013) Yves Dauvilliers et al. BRAIN
- The evolving history of influenza viruses and influenza vaccines
- (2013) Claude Hannoun Expert Review of Vaccines
- Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis
- (2013) Daniel A Salmon et al. LANCET
- Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia
- (2013) Meghann McManus et al. PEDIATRIC BLOOD & CANCER
- Safety and Utilization of Influenza Immunization in Children With Inflammatory Bowel Disease
- (2013) E. I. Benchimol et al. PEDIATRICS
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
- (2013) Stéphanie Pépin et al. VACCINE
- Live attenuated seasonal and pandemic influenza vaccine in school-age children: A randomized controlled trial
- (2013) Brendan Klick et al. VACCINE
- Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18–64 years of age
- (2013) Geoffrey J. Gorse et al. VACCINE
- International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines
- (2013) Caitlin N. Dodd et al. VACCINE
- Correlates of protection to influenza virus, where do we go from here?
- (2013) Rebecca Cox Human Vaccines & Immunotherapeutics
- A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age
- (2013) Noris Pavia-Ruz et al. Human Vaccines & Immunotherapeutics
- Surveillance for Guillain–Barré Syndrome After Influenza Vaccination Among the Medicare Population, 2009–2010
- (2012) Dale R. Burwen et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Preventing influenza in younger children
- (2012) S. Esposito et al. CLINICAL MICROBIOLOGY AND INFECTION
- Safety of influenza vaccines
- (2012) John M. Kelso Current Opinion in Allergy and Clinical Immunology
- Immunogenicity, Safety and Reactogenicity of a Mammalian Cell-Culture–Derived Influenza Vaccine in Healthy Children and Adolescents Three to Seventeen Years of Age
- (2012) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland
- (2012) Markku Partinen et al. PLoS One
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
- (2012) Hanna Nohynek et al. PLoS One
- Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects
- (2012) Hiroyuki Fukase et al. VACCINE
- A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season
- (2012) Patricia Tennis et al. VACCINE
- A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
- (2012) Christoph Hatz et al. VACCINE
- A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18–49 years of age
- (2012) Roger Baxter et al. VACCINE
- The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines
- (2012) Janet E. McElhaney et al. VACCINE
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
- (2012) David P. Greenberg et al. VACCINE
- Live attenuated intranasal influenza vaccine
- (2012) Susanna Esposito et al. Human Vaccines & Immunotherapeutics
- The rationale for quadrivalent influenza vaccines
- (2012) Christopher S. Ambrose et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6–35 Months: A Randomized, Controlled Trial
- (2012) Joanne M. Langley et al. Journal of the Pediatric Infectious Diseases Society
- Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)
- (2011) Natalie J. Carter et al. DRUGS
- An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years
- (2011) Christopher S. Ambrose et al. Influenza and Other Respiratory Viruses
- Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer
- (2011) Silvana Carr et al. JOURNAL OF INFECTIOUS DISEASES
- A clinical trial to assess the immunogenicity and safety of Inactivated Influenza Vaccine (Whole Virion) IP (Pandemic Influenza (H1N1) 2009 Monovalent Vaccine; VaxiFlu-STM) in healthy Indian adult population
- (2011) AH Kubavat et al. Journal of Postgraduate Medicine
- Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months
- (2011) D. M. Skowronski et al. PEDIATRICS
- A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older
- (2011) Bruce D. Forrest et al. VACCINE
- A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years
- (2011) Patricia Tennis et al. VACCINE
- Effectiveness and safety of influenza vaccination in children: European perspective
- (2011) Terho Heikkinen et al. VACCINE
- Immunogenicity and safety of intradermal influenza vaccine in children
- (2011) Susanna Esposito et al. VACCINE
- A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
- (2011) Stan L. Block et al. VACCINE
- A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups
- (2011) Barbara Michiels et al. VACCINE
- The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies
- (2011) Christopher S. Ambrose et al. VACCINE
- Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
- (2011) Timo Vesikari et al. VACCINE
- Adverse reactions to vaccines
- (2010) John M. Kelso et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Immunogenicity and Safety of Intradermal Influenza Vaccination in Healthy Older Adults
- (2010) Ru‐Chien Chi et al. CLINICAL INFECTIOUS DISEASES
- Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing
- (2010) Jiang Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children
- (2010) Riyadh D. Muhammad et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Evaluation of Adjuvanted Pandemic H1N12009 Influenza Vaccine After One and Two Doses in Young Children
- (2010) David W. Scheifele et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety of Influenza Vaccine Administration in Egg-Allergic Patients
- (2010) E. Y. Chung et al. PEDIATRICS
- Seasonal influenza and vaccination coverage
- (2010) Arnold S. Monto VACCINE
- Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents
- (2010) Chun-Yi Lu et al. VACCINE
- Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis
- (2010) Steven Black et al. VACCINE
- Immune Response to Influenza Vaccine in Children With Inflammatory Bowel Disease
- (2009) Ying Lu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS
- (2009) Brigitte Autran et al. Expert Review of Vaccines
- Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
- (2009) Eric Plennevaux et al. LANCET
- Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
- (2009) Michael E. Greenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Influenza A (H1N1) Vaccine in Various Age Groups
- (2009) Feng-Cai Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
- (2009) Tristan W. Clark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older
- (2009) Pierre J.T. De Villiers et al. VACCINE
- MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
- (2009) T. Vesikari et al. VACCINE
- Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience
- (2008) John Iskander et al. Expert Review of Vaccines
- Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
- (2008) Christopher S. Ambrose et al. Influenza and Other Respiratory Viruses
- Safety of the Intranasal, Trivalent, Live Attenuated Influenza Vaccine (LAIV) in Children With Intermittent Wheezing in an Open-Label Field Trial
- (2008) Manjusha J. Gaglani et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age
- (2008) Robert B. Belshe et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started